Education
About Us
Working with TipRanks
Follow Us
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
RESEARCH TOOLSreports
NEVI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.04 - C$0.15
Previous CloseN/A
Volume0.00
Average Volume (3M)36.81K
Market Cap
C$2.38M
Enterprise ValueC$2.99M
Total Cash (Recent Filing)C$51.30K
Total Debt (Recent Filing)C$467.82K
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Oct 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding39,662,727
10 Day Avg. Volume33,832
30 Day Avg. Volume36,806
Financial Highlights & Ratios
PEG Ratio-0.35
Price to Book (P/B)2.00
Price to Sales (P/S)0.00
P/FCF Ratio95.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Pascal Biosciences Inc News
PremiumCompany Announcements
Nevis Brands Expands Midwest Reach with Strategic Distribution Agreement
PremiumCompany Announcements
Nevis Brands Sees Revenue Growth Amid New Product Launches
PremiumCompany Announcements
Nevis Brands Reports 61% Revenue Growth in Q1 2025
PremiumCompany Announcements
Nevis Brands Secures $100,000 Loan from Director
PremiumCompany Announcements
Nevis Brands Expands with New Hemp-Derived THC Beverage
Options Prices
Currently, No data available
---
Ownership Overview
10.30% Insiders
―
Mutual Funds
― Other Institutional Investors
89.70% Public Companies and
Individual Investors
NEVI FAQ
What was Pascal Biosciences Inc’s price range in the past 12 months?
Pascal Biosciences Inc lowest stock price was C$0.04 and its highest was C$0.14 in the past 12 months.
What is Pascal Biosciences Inc’s market cap?
Pascal Biosciences Inc’s market cap is C$2.38M.
When is Pascal Biosciences Inc’s upcoming earnings report date?
Pascal Biosciences Inc’s upcoming earnings report date is Oct 17, 2025 which is in 92 days.
How were Pascal Biosciences Inc’s earnings last quarter?
Pascal Biosciences Inc released its earnings results on Jul 15, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Pascal Biosciences Inc overvalued?
According to Wall Street analysts Pascal Biosciences Inc’s price is currently Overvalued.
Does Pascal Biosciences Inc pay dividends?
Pascal Biosciences Inc does not currently pay dividends.
What is Pascal Biosciences Inc’s EPS estimate?
Pascal Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pascal Biosciences Inc have?
Pascal Biosciences Inc has 39,662,727 shares outstanding.
What happened to Pascal Biosciences Inc’s price movement after its last earnings report?
Pascal Biosciences Inc reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pascal Biosciences Inc?
Currently, no hedge funds are holding shares in TSE:NEVI
Company Description
Pascal Biosciences Inc
Pascal Biosciences Inc (NEVI) is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of cancer and other serious diseases. The company operates primarily in the pharmaceutical sector, leveraging its proprietary technology and expertise to create novel drug candidates. Pascal Biosciences is dedicated to advancing its pipeline through research and collaboration, aiming to bring effective solutions to patients in need.